Cargando…

Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials

BACKGROUND: Kidney function decreases during the lifetime, and this decline is a powerful predictor of both kidney and cardiovascular outcomes. Statins lower cardiovascular risk, which may relate to beneficial effects on kidney function. We studied whether atorvastatin influences kidney function dec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogt, Liffert, Bangalore, Sripal, Fayyad, Rana, Melamed, Shari, Hovingh, G. Kees, DeMicco, David A., Waters, David D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512126/ https://www.ncbi.nlm.nih.gov/pubmed/31020900 http://dx.doi.org/10.1161/JAHA.118.010827

Ejemplares similares

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin
por: Ong, Kwok Leung, et al.
Publicado: (2018)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

Safety of atorvastatin in Asian patients within clinical trials
por: Chan, Juliana C. N., et al.
Publicado: (2016)

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2015)

Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease
por: Hoogeveen, Renate M., et al.
Publicado: (2021)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
por: Basso, Paulo José, et al.
Publicado: (2021)

Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
por: Lee, Dahae, et al.
Publicado: (2021)

RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease
por: Shimizu, Chisato, et al.
Publicado: (2022)

Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
por: Moini, Abdollatif, et al.
Publicado: (2012)

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial
por: Sayyah, Mehdi, et al.
Publicado: (2015)

Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022)

Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial
por: Davoodi, Lotfollah, et al.
Publicado: (2021)

Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: Post-hoc analysis of a randomised controlled trial
por: Lim, Yuan Z., et al.
Publicado: (2022)

Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial
por: Deedwania, Prakash C., et al.
Publicado: (2015)

Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
por: Elbaum, Lindsay, et al.
Publicado: (2022)

Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial
por: van Poppel, Pleun C. M., et al.
Publicado: (2015)

Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials
por: Lubis, Andri, et al.
Publicado: (2017)

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2011)

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
por: Bangalore, Sripal, et al.
Publicado: (2016)

Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials
por: Collard, Didier, et al.
Publicado: (2020)

Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene
por: Tada, Hayato, et al.
Publicado: (2020)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
por: Deshmukh, Harshal A., et al.
Publicado: (2012)

Atorvastatin Induced Erythrocytes Membrane Blebbing
por: Rana, Rumaisa Bashir, et al.
Publicado: (2019)

Outcomes of Patients With Myeloproliferative Neoplasms Admitted With Myocardial Infarction: Insights From National Inpatient Sample
por: Leiva, Orly, et al.
Publicado: (2023)

Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)
por: Patel, Jaimin M, et al.
Publicado: (2012)

Body Fluid-Independent Effects of Dietary Salt Consumption in Chronic Kidney Disease
por: Oppelaar, Jetta J., et al.
Publicado: (2019)

Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
por: Mohammadi, Mehdi, et al.
Publicado: (2015)

Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2018)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
por: Kimer, Nina, et al.
Publicado: (2020)

Evaluation of the Effect of Atorvastatin Administration on the Outcomes of Patients with Traumatic Brain Injury: A Double-blinded Randomized Clinical Trial
por: Soltani, Farhad, et al.
Publicado: (2021)

Thymol has beneficial effects on the experimental model of ulcerative colitis
por: Tahmasebi, Pourya, et al.
Publicado: (2019)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study
por: Yoon, Jin Young, et al.
Publicado: (2019)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial
por: Raittinen, Paavo V.H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bcrk31kqsmo14qr9csn2g0m01g